Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2031

Conditions
Lung Cancer
Trial Locations (9)

IG3 8YB

RECRUITING

Barking Havering and Redbridge University Hospitals NHS Trust, Goodmayes

HD3 3EA

RECRUITING

Calderdale and Huddersfield NHS Foundation Trust, Huddersfield

CM20 1QX

RECRUITING

Princess Alexandra Hospital, London

N19 5NF

RECRUITING

Whittington Health NHS Trust, London

NW1 2BU

RECRUITING

University College London Hospitals NHS Foundation Trust, London

SE1 9RT

RECRUITING

Guy's and St Thomas' NHS Foundation Trust, London

SW3 6JJ

RECRUITING

Royal Marsden Hospital, London

NE27 0QJ

RECRUITING

Northumbria NHS Foundation Trust, Newcastle upon Tyne

NG3 6AA

RECRUITING

Nottinghamshire Healthcare NHS Foundation Trust, Nottingham

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Royal Marsden Partners West London Cancer Alliance

UNKNOWN

collaborator

Imperial College London

OTHER

collaborator

University College London Hospitals

OTHER

collaborator

Lewisham and Greenwich NHS Trust

OTHER_GOV

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Epsom and St Helier University Hospitals NHS Trust

OTHER

collaborator

King's College Hospital NHS Trust

OTHER

collaborator

University College London (UCL) Cancer Institute

OTHER

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

Francis Crick Institute

OTHER

collaborator

Royal Sussex County Hospital

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER